Search

The May 4 session of “MSK Science Spotlight” will feature series host, Andrea Schietinger, PhD, Assistant Member, Immunology Program, SKI, presenting her own research, “Decoding T Cell Dysfunction in Tumors.” Dr. Schietinger, a former winner of the prestigious National Institutes of Health Director’s New Innovator Award, has served as host for past sessions of the online seminar series for the scientific community.

Researchers shed light on how aberrant cell division can cause the kind of mutations often found in cancer cells.

An MSK research team aims to find new ways to stop the most common and deadly form of ovarian cancer — high-grade serous ovarian cancer — from recurring with the help of a method they developed for tracking the evolution of treatment resistant cells in ovarian cancer using blood tests.

David Solit, MD, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, is the featured speaker for the June 3 episode of “MSK Science Spotlight.”

Learn about the questions to ask a lung cancer doctor after being diagnosed, from an MSK specialist who has successfully treated many people for lung cancer.

Conozca las preguntas que debe hacerle a un médico especialista en cáncer pulmonar después de recibir el diagnóstico, de la mano de un especialista de MSK que ha tratado con éxito a muchas personas con cáncer pulmonar.

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that Larry Norton, MD, has been elected to the American Academy of the Arts & Sciences, and Michel Sadelain, MD, PhD, has been named the recipient of the Outstanding Achievement Award from the American Society of Gene and Cell Therapy.

Investigators have shown how gut microbes promote the formation of a type of immune cell called regulatory T cells.